Selexipag
규격
475086-01-2CAS 번호
809-991-1EC 번호
2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamideIUPAC 명칭
C26H32N4O4S화학식
496.6 g/mol분자량
Selexipag; 475086-01-2; NS-304; Uptravi; ACT-293987; NS 304; ACT 293987; 5EXC0E384L; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; ACT293987; CHEBI:90844; DTXSID301027959; 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methanesulfonyl)acetamide; 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-methanesulfonylacetamide; 2-(4-((5,6-Diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy}-n-(methanesulfonyl)acetamide; selexipagum; 2-(4-((5,6-di(phenyl)pyrazin-2-yl)-propan-2-ylamino)butoxy)-N-methylsulfonylacetamide; 2-(4-((5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino)butoxy)-N-(methylsulfonyl)acetamide; 2-(4-((5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino)butoxy)-N-methanesulfonylacetamide; 2-[4-[[5,6-di(phenyl)pyrazin-2-yl]-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide; 2-(4-((5,6-DIPHENYLPYRAZIN-2-YL)(PROPAN-2-YL)AMINO)BUTOXY)-N-(METHANESULFONYL)ACETAMIDE; Uptravi Titration Pack; RefChem:58598; Selexipag TITRATION PACK; B01AC27; DTXCID501513526; 2-(4-((5,6-diphenylpyrazin-2-yl)(isopropyl)amino)butoxy)-N-(methylsulfonyl)acetamide; MFCD10567093; 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide; NS-304;ACT-293987; Selexipag [USAN:INN]; UNII-5EXC0E384L; C26H32N4O4S; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-N-(methylsulfonyl)acetamide; 2-[4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide; ACT 293987; NS 304; Uptravi;; Uptravi (TN); Selexipag (Standard); NS-304(Selexipag); Selexipag(NS-304); SELEXIPAG [INN]; SELEXIPAG [JAN]; SELEXIPAG [MI]; SELEXIPAG [USAN]; NS-304(Selexipag)?; SELEXIPAG [WHO-DD]; Selexipag (JAN/USAN/INN); SCHEMBL674122; CHEMBL238804; GTPL7552; orb1304415; SELEXIPAG [ORANGE BOOK]; SCHEMBL29360518; QXWZQTURMXZVHJ-UHFFFAOYSA-N; GLXC-27569; HMS5082O03; EX-A7991; BDBM50235383; EBC-13811; HY-14870R; s3726; AKOS024457572; CCG-269668; CS-3774; DB11362; SB17055; 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide; NCGC00370833-01; NCGC00370833-02; AC-30209; BS-16872; FD106425; HY-14870; SY236548; DB-119997; NS00069732; D09994; EN300-7378417; BRD-K21191422-001-01-5; Q15424759; 2-[4-[(5,6-Diphenyl-2-pyrazinyl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide; 2-[4-[(5,6-diphenylpyrazin-2-yl)-isopropyl-amino]butoxy]-N-methylsulfonyl-acetamide; Selexipag Micronized동의어
Selexipag 함유 제품
업트라비정600마이크로그램(셀렉시팍)업트라비정400마이크로그램(셀렉시팍)업트라비정800마이크로그램(셀렉시팍)업트라비정200마이크로그램(셀렉시팍)ウプトラビ錠0.2mg/ウプトラビ錠0.4mg/ウプトラビ錠0.8mgウプトラビ錠小児用0.05mgUPTRAVI 800 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 600 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 400 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 200 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 1600 MCG COMPRIMIDOS RECUBIERTOS CON PELICULAUPTRAVI 1400 MCG COMPRIMIDOS RECUBIERTOS CON PELICULA
1/6 페이지
Selexipag 판매 기업
ML
MSN LaboratoriesIndiaSI
Sinoway Industrial Co.Ltd.ChinaAP
Alicorn Pharmaceutical Co., LtdChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaAP
Apotex PharmachemCanadaCH
ChemoSpainNC
Nuray Chemicals Private LimitedIndia1/3 페이지